Medtronic received information via literature regarding leaflet tears and aortic regurgitation (ar) following bioprosthetic valve implant.All data were collected from a single center between january 1993 and may 2011.The study population included 430 patients (predominantly male; mean age 60 years), all of which were implanted with a medtronic freestyle bioprosthetic valve (serial numbers not provided).Among all patients, one death occurred due to multi-organ failure.This death was not attributed to medtronic product.Among all patients adverse events included: structural valve dysfunction requiring reoperation, dyspnea, mild calcification, elevated gradients, stenosis, and heart failure.The following are 20 patients (specific identifiers or demographics not provided) were summarized with these adverse effects: patient 1: cardiogenic shock, pulmonary edema, leaflet tear, severe ar.Patient 2: pulmonary edema, leaflet tear, severe ar.Patient 3: cardiogenic shock, pulmonary edema, leaflet tear, mild calcification, severe ar.Patient 4: pulmonary edema, leaflet tear , mild calcification, severe ar.Patient 5: pulmonary edema, leaflet tear, severe ar.Patient 6: pulmonary edema, mild calcification, leaflet tear, severe ar.Patient 7: pulmonary edema, leaflets tear, moderate ar.Patient 8: severe ar, leaflet tear.Patient 9: pulmonary edema, leaflet tear, moderate ar.Patient 10: leaflet tear, severe ar.Patient 11: pulmonary edema, leaflet tear, mild calcification, severe ar.Patient 12: leaflet tear, mild calcification, severe ar.Patient 13: leaflet tear, severe ar.Patient 14: leaflets tear, mild calcification, moderate ar.Patient 15: leaflet tear, severe ar.Patient 16: leaflet tear, mild calcification, severe ar.Patient 17: pulmonary edema, leaflet tear, mild calcification, moderate ar.Patient 18: leaflet tear, mild calcification, severe ar.Patient 19: leaflet tear, mild calcification, severe ar.Patient 20: leaflet tear, mild calcification, severe ar.No additional adverse patient effects were reported.
|